Hyderabad, 27th January 2025: Trade and Investment Queensland (TIQ), the Queensland Government’s dedicated business agency presented a 20 member high profile delegation, in the gracious presence of Her Excellency, Honourable Governor of Queensland Dr. Jeanette Young, along with The Honourable Minister for Finance, Trade, Employment, and Training in Queensland, Ros Bates at BioAsia 2025. Named as the Global Sponsor for BioAsia 2025, TIQ anchored several engagements at Asia’s premier life sciences and biotechnology forum, organized annually by the Government of Telangana, India. This strategic partnership reinforces both regions’ commitment to driving innovation, fostering high-impact research, and accelerating advancements in global healthcare.
With a strong focus on fostering synergies between Telangana and Queensland, the TIQ delegation highlighted India’s pivotal role in global innovation, with Hyderabad positioned at the forefront of IT, research, and healthcare. Professor Alan Rowan, Director and Interim Pro Vice-Chancellor (Research Infrastructure) at the Australian Institute for Bioengineering and Nanotechnology, University of Queensland (UQ), underscored India’s unique potential to become a frontier leader in scientific research, backed by its massive IT prowess and research advancements.
Addressing the media, Alan said, “Hyderabad is rapidly evolving into a world-class center for healthcare infrastructure and cutting-edge research. The city is now seamlessly connected with global innovation hubs like Boston, Singapore, and Queensland, accelerating its position as a powerhouse in biotechnology, medical research, and engineering.”
He was joined by leading experts from Queensland’s research and healthcare ecosystem, including:
- Prof. Trent Munro, Director, Biotechnology Innovation, UQ
- Dr. Romain Tropée, Head of Science and Technology, Southern RNA (SRNA)
- Prof. Evelin Tiralongo, Director, Clinical Trial Unit, Griffith University
- Chris Peck, Chief Executive Officer, SRNA
- Dr. Teck Jack TAN, Chief Medical Officer, TeleMedC Pty Ltd
- Professor Prasad Yarlagadda, Dean, Engineering, University of Southern Queensland (UniSQ)
- Shannon Willoughby, Executive Director, Strategic Partnerships Office, UQ
- Sarah Costanzo, Associate Director, Advanced Manufacturing and Deep Technologies, UQ
- Saravanan Nagarathinam, Manager Strategy and Partnerships, UQ
- Dr. Harpreet Johal-Meredith, Business Development Director, Resolian Bioanalytics Brisbane
- Thomas Lake, Senior Vice President, Vaccine Alliances & Commercialization, Vaxxas
- Michael Power, Global Director – Sales, HealthCare Logic
- Dr Christopher Ogg, Founder, HealthCare Logic
- Chris Reid, Platform Sales Professional, HealthCare Logic
- Brett Sellars, Hospital Engagement Lead, HealthCare Logic
- Priyanka Risikesan, Deputy Chief Technology Officer, HealthCare Logic
- Prof Rajiv Khanna, Co-Director, Queensland Immunology Research Centre, QIMR
- Dr Rajiv Tyagi, Head of Strategic Commercial Alliances, QIMR
- Anand Gautam, Founder, G2Ome Consulting Pty Ltd,
The discussions highlighted the scope for joint research, clinical trials, and technology-driven solutions between India and Queensland. The collaboration is expected to drive new investments and foster deeper scientific cooperation. Adding to the conversation, Abhinav Bhatia, Senior Trade & Investment Commissioner – South Asia, Trade and Investment Queensland, said that “BioAsia 2025 to deepen Queensland’s engagement with India’s thriving life sciences and technology ecosystem. With India being the world’s pharmacy and Queensland being a research powerhouse, this dynamic collaboration enables breakthroughs that contribute to the advancement of global healthcare.”
This strategic engagement between Telangana and Queensland reaffirms Hyderabad’s position as a global leader in science, healthcare, and innovation, paving the way for transformative advancements in the sector.